These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18795086)

  • 1. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
    Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcome of two patients treated with imatinib.
    Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
    Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
    Heartin E; Walkinshaw S; Clark RE
    Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
    Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
    Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
    Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
    Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
    [No Abstract]   [Full Text] [Related]  

  • 6. Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.
    Hardling M; Wei Y; Palmqvist L; Swolin B; Stockelberg D; Gustavsson B; Ekeland-Sjöberg K; Wadenvik H; Ricksten A
    Med Oncol; 2004; 21(4):349-58. PubMed ID: 15579919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
    Kobayashi K; Takebayashi C; Miyata S; Narimatsu H; Kami M
    Intern Med; 2009; 48(5):369-71. PubMed ID: 19252364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
    Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
    Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
    Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.
    Mukhopadhyay A; Dasgupta S; Kanti Ray U; Gharami F; Bose CK; Mukhopadhyay S
    Ir J Med Sci; 2015 Mar; 184(1):183-8. PubMed ID: 24590821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
    Suppiah R; Kalaycio M
    Leuk Lymphoma; 2006 Jun; 47(6):1149-50. PubMed ID: 16840209
    [No Abstract]   [Full Text] [Related]  

  • 12. Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.
    Kuwabara A; Babb A; Ibrahim A; Milojkovic D; Apperley J; Bua M; Reid A; Foroni L; Rezvani K; Goldman J; Marin D
    Blood; 2010 Aug; 116(6):1014-6. PubMed ID: 20705771
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
    Yadav U; Solanki SL; Yadav R
    J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate in the treatment of chronic myelogenous leukemia.
    Borthakur G; Cortes JE
    Int J Hematol; 2004 Jun; 79(5):411-9. PubMed ID: 15239390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature.
    Cole S; Kantarjian H; Ault P; Cortés JE
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):324-7. PubMed ID: 19717385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia.
    Oliveira GA; Costa ES; Freitas MS; Dutra FF; Maia SF; Guerra MC; Tabernero MD; Borojevic R; Otazu IB; Silva JL
    Braz J Med Biol Res; 2010 Jun; 43(6):580-4. PubMed ID: 20396859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
    Iqbal J; Ali Z; Khan AU; Aziz Z
    Leuk Lymphoma; 2014 Sep; 55(9):2109-13. PubMed ID: 24237577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib.
    Garderet L; Santacruz R; Barbu V; van den Akker J; Carbonne B; Gorin NC
    Haematologica; 2007 Jan; 92(1):e9-10. PubMed ID: 17405743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia.
    Wang L; Pearson K; Pillitteri L; Ferguson JE; Clark RE
    Br J Haematol; 2002 Sep; 118(3):771-7. PubMed ID: 12181044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopathologic and cytogenetic findings in imatinib mesylate treated chronic myelogenous leukemia patients: 2.5 years' experience.
    Cojbasić I; Macukanović-Golubović L
    Vojnosanit Pregl; 2010 Oct; 67(10):802-6. PubMed ID: 21061842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.